Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2024. At this time, all participants are in a listen-only mode.
Rigel Pharmaceuticals Inc (RIGL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 1,536,000 | $22,732,800 | -11% | 0.3% |
| 2. | Soleus Capital Guy Levy | 924,198.6 | $13,678,139 | -3% | 1.01% |
| 3. | Millennium Management Israel Englander | 187,298.8 | $2,772,022 | +142% | 0% |
| 4. | Stonepine Capital Timothy P. Lynch | 104,024.1 | $1,539,557 | 1.22% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 62,319.1 | $922,323 | -6% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.69 | 1,000,000 | Officer, Director | 1,391,776 | 2022-06-09 | Filing | |
| $2.13 | 3,274 | Officer | 50,000 | 2019-05-22 | Filing | |
| $2.13 | 46,726 | Officer | 46,726 | 2019-05-22 | Filing | |
| $3.23 | 50,000 | Officer | 215,000 | 2018-09-11 | Filing | |
| $3.28 | 50,000 | Officer | 165,000 | 2018-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.14 | 8,918 | 349,093 | 2024-02-05 | Filing | ||
| $1.13 | 5,601 | 358,011 | 2024-02-02 | Filing | ||
| $1.14 | 7,027 | 402,891 | 2024-02-05 | Filing | ||
| $1.13 | 5,601 | 409,918 | 2024-02-02 | Filing | ||
| $1.14 | 30,545 | 2,036,629 | 2024-02-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,519,807.7 | $22,037,211 | 0% | |
| 2. | 1,445,511.4 | $20,959,916 | 0% | |
| 3. | 895,321.7 | $12,982,165 | 0% | |
| 4. | 369,269.9 | $5,355,011 | 0% | |
| 5. | 358,007.7 | $5,191,112 | 0% |
News See All
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2023. At this time, all participants are in a listen-only mode.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Third Quarter of 2023. At this time, all participants are in listen-only mode.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Second Quarter of 2023. At this time, all participants are in a listen only mode.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the First Quarter of 2023. At this time, all participants are in a listen only mode.
12 Best Low-Priced Growth Stocks To Buy
The US stock market is showing signs of unprecedented resilience, defying expectations of several analysts and hedge fund managers, including the Big Short Michael Burry, who recently said in a tweet ...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Year End 2022. At this time, all participants are in a listen only mode.
Hedge Funds Are Crazy About Rigel Pharmaceuticals, Inc. (RIGL)
In this article we are going to use hedge fund sentiment as a tool and determine whether Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a good investment right now.
Hedge Funds Are Crazy About Rigel Pharmaceuticals, Inc. (RIGL)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Were Hedge Funds Right About Rigel Pharmaceuticals, Inc. (RIGL)?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Billionaire Hedge Funds
